Posted on 9/25/18
Polaris Strategic Solutions Launches Partnership with Innovative Consulting Group
Healthcare reporting firm Polaris Strategic Solutions http://www.polarisstrategic.com announced today that it has entered into a sales partnership with healthcare IT consulting firm Innovative Consulting Group (ICG) . . .
Posted on 9/25/18
Tris Pharma Expands ADHD Portfolio with Acquisition of NextWave Pharmaceuticals
Tris Pharma, Inc. (Tris), a pharmaceutical company focused on developing innovative technology-based therapeutic products that address unmet patient needs
Posted on 9/25/18
BioRestorative Therapies Announces Metabolic Research Collaboration with University of Pennsylvania
MELVILLE, N.Y., Sept. 24, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, . . .
Posted on 9/23/18
MRO Launches Medical Record Attachment Solution for Hospital and Health System Business Offices
MRO, a leader in the secure, compliant and efficient exchange of protected health information (PHI), announced today the general availability of its business office medical record . . .
Posted on 9/21/18
Buy This Stock If You Are Afraid Of An Imminent Bear Market
SummaryBear markets cause traumatic experiences to most investors.Many investors have missed the ongoing bull market due to their fear of an imminent bear market.In this article, . . .
Posted on 9/20/18
Penn State Health and Humana Announce Medicare Network Agreement in South Central Pennsylvania
HERSHEY, Pa. & LOUISVILLE, Ky.--(BUSINESS WIRE)--Penn State Health and Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, have signed an agreement . . .
Posted on 9/20/18
Daiichi Sankyo Announces Clinical Research Collaboration
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that it has entered into a clinical trial collaboration agreement with a subsidiary of Merck & Co., Inc., . . .
Posted on 9/20/18
Amicus Therapeutics Acquires Gene Therapy Portfolio of Ten Clinical and Pre-Clinical Stage AAV Programs in Neurologic Lysosomal Storage Disorders
CRANBURY, N.J., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced the signing of a definitive agreement in which Amicus Therapeutics will receive . . .
Posted on 9/20/18
Pfizer And Conatus: Emricasan And NASH
SummaryPfizer has proven itself to be a pioneer of therapeutics for HIV infection, autoimmune, cardiovascular and gastrointestinal diseases as well as hematological and oncological ailments.Pfizer had . . .
Posted on 9/20/18
Synchronoss Technologies Reports Inducement Grants to Employees Under Nasdaq Listing Rule 5635(c)(4)
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Synchronoss Technologies, Inc. (SNCR), a global leader and innovator in cloud, messaging, digital, and IoT products and platforms, today announced that the Company issued . . .
Posted on 9/19/18
PLEXIS Healthcare Systems and Santéch Announce a Strategic Partnership
PLEXIS Healthcare Systems, a global provider of core payer technologies for healthcare claims administration, and Santéch, a leading provider of innovative solutions through the I-Network platform . . .
Posted on 9/19/18
Targeted Oncology Launches its Latest Virtual Tumor Board on Multiple Myeloma
CRANBURY, N.J.--(BUSINESS WIRE)--Targeted Oncology, a print and digital resource that offers content and expert opinions on standard and emerging treatments in the oncology field, will launch . . .
Posted on 9/19/18
Celgene Yields The Most
SummaryCelgene continues to boost EPS estimates while the stock trades at multi-year lows.Revlimid faces patent questions that aren't likely to disappear, making the large pipeline important . . .
Posted on 9/18/18
BioAegis Therapeutics Enrolls First Patients in Phase 1b/2a Community-Acquired Pneumonia Study and Raises $4 MM in Equity Round
MORRISTOWN, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. announced that it has begun patient enrollment in a Phase 1b/2a study of recombinant plasma . . .
Posted on 9/18/18
CSL Named One of the Top Companies in the World for Diversity and Inclusion
Thomson Reuters has ranked global biotechnology leader CSL Limited one of the top 100 companies in its 2018 global Diversity and Inclusion Index. This achievement reflects . . .
Posted on 9/18/18
AGS Health Listed in the 2018 100 Best Companies for Women in India List
AGS Health Inc., a global healthcare revenue cycle management company has been named for the third year in a row to the prestigious 2018 100 Best . . .
Posted on 9/18/18
Penn Dental Medicine Awarded $1M Scholarship Grant from Delta Dental Community Care Foundation
PHILADELPHIA--(BUSINESS WIRE)--Penn Dental Medicine students with a passion for serving vulnerable patients will now have a new resource to support their interests and goals thanks to . . .
Posted on 9/18/18
Teva Announces Early Results of Debt Tender Offer and Election of Early Settlement
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today the early tender results in connection with its previously announced tender offers to purchase for cash for a . . .
Posted on 9/18/18
Better Buy: Celgene Corp. vs. Biogen
The biopharmaceutical sector is expected to be one of the most profitable areas for investors over the next decade. Ground-breaking technologies such as next-generation gene-editing systems, . . .
Posted on 9/18/18
Eleven Finalists Selected for $100K Pediatric Medical Device Competition
Eleven finalists will pitch their pediatric medical device innovation during the annual "Make Your Medical Device Pitch for Kids!" competition at the Sixth Annual Pediatric Device . . .
Posted on 9/17/18
Aramark To Sell Its Healthcare Technologies Business For $300M To TRIMEDX
Aramark (NYSE: ARMK) announced today that it has signed a definitive agreement to sell its Healthcare Technologies (HCT) business for $300 million to TRIMEDX.
Posted on 9/17/18
Realm Therapeutics Provides Corporate Update and Hires Advisor to Support Strategic Review including Formal Sale Process
Realm Therapeutics plc (NASDAQ: RLM / AIM: RLM), a biopharmaceutical company with a proprietary technology platform of stabilized high concentration hypochlorous acid (HOCl), today provides a . . .
Posted on 9/17/18
Why bluebird and Celgene Should Worry About Amgen's Latest Clinical Victory
The market for complex therapies that train living cells to attack cancer is taking baby steps, but there's still a lot of enthusiasm for experimental drugs . . .
Posted on 9/17/18
Celgene Corp. (CELG) Presents at Morgan Stanley Global Healthcare Conference Call Transcript
Celgene Corp. (NASDAQ:CELG) Morgan Stanley Global Healthcare Conference Call September 14, 2018 11:40 AM ETExecutivesNadim Ahmed - President, Hematology & OncologyDavid Elkins - CFOAnalystsMatthew Harrison - . . .
Posted on 9/17/18
Pfizer Invests In Mini Brains, Kleiner Perkins Splits
Welcome to Seeking Alpha’s Venture Capital Deals of the Week. Follow this account and turn on the e-mail alert to receive VCDeals in your inbox on . . .

